Therapeutic drug monitoring of antimicrobials

被引：16
|
作者：
Balakrishnan, Indran [1 ,2 ]
Shorten, Robert J. [2 ,3 ]
机构：
[1] Royal Free London NHS Fdn Trust, Dept Med Microbiol, London, England
[2] UCL, Ctr Clin Microbiol, Royal Free Campus, London, England
[3] Manchester Royal Infirm, Publ Hlth Lab Manchester, Oxford Rd, Manchester M13 9WL, Lancs, England
来源：
ANNALS OF CLINICAL BIOCHEMISTRY | 2016年 / 53卷 / 03期
关键词：
Antimicrobial therapy; therapeutic drug monitoring; ESCHERICHIA-COLI; DISSEMINATED CANDIDIASIS; ORAL POSACONAZOLE; BRITISH SOCIETY; AMPHOTERICIN-B; PHARMACOKINETICS; VORICONAZOLE; GENTAMICIN; VANCOMYCIN; SAFETY;
D O I：
10.1177/0004563215618981
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
As pathology services become more centralized and automated, the measurement of therapeutic antimicrobial drugs concentrations is increasingly performed in clinical biochemistry or blood science' laboratories. This review outlines key groups of antimicrobial agents: aminoglycosides, glycopeptides, antifungal agents and antituberculosis agents, their role in managing infectious diseases, and the reasons why serum concentration measurement is important.
引用
收藏
页码：333 / 346
页数：14
相关论文
共 50 条
  • [41] Therapeutic drug monitoring of voriconazole
    Bruggemann, Roger J. M.
    Donnelly, J. Peter
    Aarnoutse, Rob E.
    Warris, Adilia
    Blijlevens, Nicole M. A.
    Mouton, Johan W.
    Verweij, Paul E.
    Burger, David M.
    THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 403 - 411
  • [42] Therapeutic drug monitoring for triazoles
    Hope, William W.
    Billaud, Eliane M.
    Lestner, Jodie
    Denning, David W.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (06) : 580 - 586
  • [43] Therapeutic drug monitoring in neonates
    Pauwels, Steven
    Allegaert, Karel
    ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (04) : 377 - 381
  • [44] Therapeutic Drug Monitoring of antiinfectives in intensive care medicine
    Nosseir, N. S.
    Michels, G.
    Pfister, R.
    Adam, R.
    Wiesen, M. H. J.
    Mueller, C.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (38) : 1889 - 1894
  • [45] Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
    Thompson, George R., III
    Rinaldi, Michael G.
    Pennick, Gennethel
    Dorsey, Sheryl A.
    Patterson, Thomas F.
    Lewis, James S., II
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 2223 - 2224
  • [46] Approaches for posaconazole therapeutic drug monitoring and their clinical benefits
    Wang, Silu
    Li, Changkun
    Dong, Yalin
    Dong, Weihua
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (12) : 1845 - 1855
  • [47] Impact of Triazole Therapeutic Drug Monitoring Availability and Timing
    McCreary, Erin K.
    Bayless, Meg
    Van, Ahn P.
    Lepak, Alexander J.
    Wiebe, Donald A.
    Schulz, Lucas T.
    Andes, David R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (10)
  • [48] Fluconazole Therapeutic Drug Monitoring in Children With Cancer: Not Today
    Cohen-Wolkowiez, Michael
    Benjamin, Daniel K., Jr.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (11) : 1534 - 1536
  • [49] Therapeutic drug monitoring of amikacin in preterm and term infants
    Siddiqi, A.
    Khan, D. A.
    Khan, F. A.
    Razzaq, A.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (05) : 486 - 489
  • [50] Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
    Aquino, Maria
    Tinoco, Maria
    Bicker, Joana
    Falcao, Amilcar
    Rocha, Marilia
    Fortuna, Ana
    ANTIBIOTICS-BASEL, 2023, 12 (02):
12345